SCANDIUM INTERNATIONAL MINING CORP. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SCANDIUM INTERNATIONAL MINING CORP. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $47.2K | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $850.6K | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | ($1.57M) | Mar 7, 2023 |
| FY2022 | Dec 31, 2020 | ($1.39M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($1.95M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($2.96M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($2.79M) | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | ($2.11M) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | ($2.77M) | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | ($1.85M) | Mar 16, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | ($1.59M) | Mar 11, 2022 |
| FY2022 | Dec 31, 2020 | $1.74M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($1.95M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($2.90M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($2.92M) | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | ($1.97M) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | ($2.68M) | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | ($1.67M) | Mar 16, 2016 |
| FY2014 | Dec 31, 2013 | ($1.30M) | Mar 2, 2015 |
| FY2013 | Dec 31, 2012 | ($2.69M) | Mar 25, 2014 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $3.04M | Mar 25, 2014 |
| FY2012 | Dec 31, 2012 | $0 | Mar 28, 2013 |
| FY2012 | Dec 31, 2011 | $0 | Mar 28, 2013 |
| FY2011 | Dec 31, 2010 | $0 | Feb 14, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($830.8K) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($947.7K) | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | ($374.2K) | Mar 7, 2023 |
| FY2022 | Dec 31, 2020 | $82.0K | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($1.13M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($1.79M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($1.55M) | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | ($1.63M) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | ($2.01M) | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | ($1.64M) | Mar 16, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $8.4K | Feb 28, 2020 |
| FY2017 | Dec 31, 2017 | $0 | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $3.2K | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $0 | Mar 16, 2017 |
| FY2013 | Dec 31, 2013 | $19.92M | Mar 25, 2014 |
| FY2013 | Dec 31, 2012 | $3.3K | Mar 25, 2014 |
| FY2012 | Dec 31, 2011 | $40.9K | Mar 28, 2013 |
| FY2011 | Dec 31, 2010 | $90.3K | Feb 14, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.78M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $2.60M | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | $847.4K | Mar 7, 2023 |
| FY2022 | Dec 31, 2020 | $932.9K | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $883.8K | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.05M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.10M | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $1.37M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $3.30M | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | $3.49M | Mar 16, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $349.3K | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $1.51M | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | $1.73M | Mar 7, 2023 |
| FY2022 | Dec 31, 2020 | $1.15M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $538.2K | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $146.6K | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $66.2K | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $41.4K | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $207.3K | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | $2.57M | Mar 16, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.43M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $1.09M | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | ($880.3K) | Apr 1, 2024 |
| FY2023 | Dec 31, 2020 | ($221.5K) | Mar 7, 2023 |
| FY2022 | Dec 31, 2019 | $345.6K | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $901.9K | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.03M | Feb 28, 2020 |
| FY2017 | Dec 31, 2016 | $2.42M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $4.06M | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | $920.7K | Mar 16, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($114.91M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($114.95M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | ($115.80M) | Mar 7, 2023 |
| FY2022 | Dec 31, 2020 | ($114.24M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($112.85M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($110.90M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($107.94M) | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | ($93.45M) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | ($91.34M) | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | ($88.57M) | Mar 16, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $785.1K | Mar 25, 2014 |
| FY2013 | Dec 31, 2012 | $190.2K | Mar 25, 2014 |
| FY2013 | Dec 31, 2011 | $791.4K | Mar 25, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2013 | Dec 31, 2013 | 0 | Mar 25, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Mar 25, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 0 | Mar 25, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Mar 25, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 355.86M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | 355.86M | Apr 1, 2024 |
| FY2023 | Dec 31, 2021 | 317.16M | Mar 7, 2023 |
| FY2022 | Dec 31, 2020 | 314.03M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | 312.48M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 304.78M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 291.97M | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | 225.05M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | 225.05M | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | 198.60M | Mar 16, 2016 |